51
EUTECTIC FORMULATIONS OF CYCLOBENZAPRINE HYDROCHLORIDE. October 5, 2017: US20170281568-A1

The present invention relates to pharmaceutical compositions and methods of manufacturing the same, comprising a eutectic of Cyclobenzaprine HCl and mannitol.


52
RANKL-SPECIFIC AGENT FOR TREATING METASTATIC DISEASE. Probiocon, November 9, 2017: US20170319687-A1

The invention provides for a RANKL-specific antagonistic agent recognizing human platelet-expressed receptor activator of nuclear factor kappa-B ligand (pRANKL), for use in treating a cancer patient to prevent or reduce premetastatic lesions in blood.


53
THERAPEUTIC AGENT FOR PAIN. ASTELLAS PHARMA, November 16, 2017: US20170327474-A1

[Problem] Provided is a pharmaceutical, in particular, a pharmaceutical composition which is useful for the treatment of pain. [Means for Solution] The present inventors have made extensive studies using model animals with pain for the purpose of providing a therapeutic agent for pain. As a result, ...


54
THERMORESPONSIVE CELL CULTURE SUPPORTS. November 30, 2017: US20170342375-A1

The present invention relates to a cell culture support comprising a substrate and a polymeric blend layer bound to the substrate. The polymeric blend layer comprises at least one thermoresponsive polymer and at least one coupling agent. The coupling agent is a non-protein coupling agent that has fu ...


55
DELIVERY SYSTEM FOR INFLATABLE IMPLANT. December 14, 2017: US20170354491-A1

An implant delivery system can be used to deliver an implant into a body. The implant delivery system can include an inflation tube and a tubular member surrounding the inflation tube. The inflation tube can be used to provide an inflation medium to the implant. The tubular member can have a distal ...


56
RECOMBINANT PHE-FREE PROTEINS FOR USE IN THE TREATMENT OF PHENYLKETONURIA. NEXTTOBE, January 18, 2018: US20180016613-A1

The present invention relates to a method for preparing a recombinant Phe-free or Phe-low protein, the method comprising using B. subtilis or B. licheniformis as an expression system and/or a recombinant host cell into which a nucleotide encoding a recombinant Phe-free or Phe-low protein has been in ...



Click the thumbnails below to visualize the patent trend.